Second rhabdoid tumor 8 years after treatment of atypical teratoid/rhabdoid tumor in a child with germline SMARCB1 mutation

Pediatr Blood Cancer. 2019 Mar;66(3):e27546. doi: 10.1002/pbc.27546. Epub 2018 Nov 4.

¹ Division of Hematology/Oncology, Department of Pediatrics, McMaster Children's Hospital, McMaster University, Hamilton, Ontario, Canada.
² Pediatric Brain Tumour Program, The Hospital for Sick Children, University of Toronto, Ontario, Canada.
³ Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Ontario, Canada.
⁴ Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
⁵ Department of Laboratory Medicine and Pathology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

No abstract available

Publication types